StockData
MIRA Pharmaceuticals, Inc. logo

MIRA Pharmaceuticals, Inc. (MIRA) stock

MIRANasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 6/30
$0.59−0.05 (-7.66%)

Close on Nov 18, 2026Market cap $24.84MP/E –Yield –

MIRA Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

MIRA Pharmaceuticals's enterprise value was $18.03M on Nov 11, 2026, against $50.94M a year earlier. Over the last 3 years it ranged from $3.53M to $62.62M, with a median of $21.45M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$18.03M-65.4%
2025Dec 31, 2025$52.13M+433.9%
2024Dec 31, 2024$9.76M+69.2%
2023Dec 29, 2023$5.77M–

More MIRA Pharmaceuticals figures

See a number that looks wrong?